Intracranial dissemination of a macroprolactinoma

J. Assies, N. P. Verhoeff, D. A. Bosch, L. J. Hofland

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)

Abstract

A patient with a macroprolactinoma and extrasellar extension was treated by incomplete transfrontal surgery, external irradiation and additional bromocriptine (Br) treatment. After 4 years, partial bromocriptine resistance developed (a rare occurrence) together with the appearance of intracranial metastases. 123I-Iodobenzamide was helpful in evaluating the dopamine D2 receptor status of the metastatic tumour both in vivo using single-photon emission computed tomography (SPECT) and in vitro. Prolactin release by the cultured metastatic tumour cells was more potently inhibited by CV 205-502 than by bromocriptine. The patient, treated by surgery, irradiation and CV 205-502, developed a ptosis of the left eye and a transient psychiatric delusional state, the latter probably an effect of the dopamine agonist. As the right frontal metastasis was markedly positive on SPECT with 111In-SMS, somatostatin treatment was added to the CV 205-502
Original languageEnglish
Pages (from-to)539-546
JournalClinical endocrinology
Volume38
Issue number5
DOIs
Publication statusPublished - 1993

Cite this